FDA.reportPublic FDA data

triamcinolone hexacetonide 20 MG/ML Injectable Suspension

RxCUI
1085996
RxNorm name
triamcinolone hexacetonide 20 MG/ML Injectable Suspension
Display name
Triamcinolone (Injectable)
Full name
triamcinolone hexacetonide 20 MG/ML Injectable Suspension
Term type
SCD
Status
Active
Strength
20 mg/ml
Dose form
Susp
Route
Injectable
Updated
2026-06-14 07:05:34

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
022011
Active start
022011
Multiple ingredient
NO
Branded
NO

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
triamcinolone hexacetonide20 MG / 1 MLtriamcinolonetriamcinolone hexacetonide

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injectable Suspension316950

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
triamcinolone10759

Source Vocabulary Codes#

Code type, Value, Category table
Code typeValueCategory
PRESCRIBABLEYATTRIBUTES
RXNAV_STRtriamcinolone hexacetonide 20 MG/ML Injectable SuspensionNAMES
RxNorm Nametriamcinolone hexacetonide 20 MG/ML Injectable SuspensionNAMES
TTYSCDATTRIBUTES
RxCUI1085996CODES
MMSL_CODECD3387CODES

RxNav Current And Historical NDCs#

NDC11, Source, Active table
NDC11SourceActive
00205450524rxnav_historical_indirect
00205450531rxnav_historical_indirect
00469511901rxnav_historical_indirect
00469511905rxnav_historical_indirect
00781308571rxnav_historical_indirect
00781308575rxnav_historical_indirect
12698105500rxnav_historical_indirect
12698105501rxnav_historical_indirect
54643010550rxnav_historical_indirect
54643010560rxnav_historical_indirect
54643105500rxnav_historical_indirect
54643105501rxnav_historical_indirect
54643105600rxnav_historical_indirect
57317020501rxnav_historical_indirect
57317020505rxnav_historical_indirect
58016485501rxnav_historical_indirect

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCC05AACorticosteroidsATC1-4triamcinolone
ATCR01ADCorticosteroidsATC1-4triamcinolone
ATCA01ACCorticosteroids for local oral treatmentATC1-4triamcinolone
ATCD07ABCorticosteroids, moderately potent (group II)ATC1-4triamcinolone
ATCD07XBCorticosteroids, moderately potent, other combinationsATC1-4triamcinolone
ATCS01BACorticosteroids, plainATC1-4triamcinolone
ATCR03BAGlucocorticoidsATC1-4triamcinolone
ATCH02ABGlucocorticoidsATC1-4triamcinolone
FDASPLN0000175576CorticosteroidEPChas_epctriamcinolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moatriamcinolone
MEDRTD014221TriamcinoloneCHEMhas_ingredienttriamcinolone
MEDRTD014222Triamcinolone AcetonideCHEMhas_ingredienttriamcinolone hexacetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone hexacetonide
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treattriamcinolone
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone hexacetonide
MEDRTD000743Anemia, HemolyticDISEASEmay_treattriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventtriamcinolone hexacetonide
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventtriamcinolone hexacetonide
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone
MEDRTD001249AsthmaDISEASEmay_preventtriamcinolone hexacetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone hexacetonide
MEDRTD001607BerylliosisDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone
MEDRTD001986Bronchial SpasmDISEASEmay_treattriamcinolone hexacetonide
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treattriamcinolone hexacetonide
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treattriamcinolone hexacetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone hexacetonide
MEDRTD003876Dermatitis, AtopicDISEASEmay_treattriamcinolone
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone hexacetonide
MEDRTD004342Drug HypersensitivityDISEASEci_withtriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone
MEDRTD004892Erythema MultiformeDISEASEmay_treattriamcinolone hexacetonide
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone
MEDRTD005148Facial DermatosesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD005533Foot DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone
MEDRTD006229Hand DermatosesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone hexacetonide
MEDRTD006934HypercalcemiaDISEASEmay_treattriamcinolone
MEDRTD007239InfectionsDISEASEci_withtriamcinolone hexacetonide
MEDRTD007239InfectionsDISEASEci_withtriamcinolone
MEDRTD007249InflammationDISEASEmay_treattriamcinolone hexacetonide
MEDRTD007249InflammationDISEASEmay_treattriamcinolone
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD007868Leg DermatosesDISEASEmay_treattriamcinolone
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone hexacetonide
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone
MEDRTD009103Multiple SclerosisDISEASEmay_treattriamcinolone hexacetonide
MEDRTD009181MycosesDISEASEci_withtriamcinolone
MEDRTD009181MycosesDISEASEci_withtriamcinolone hexacetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone hexacetonide
MEDRTD009404Nephrotic SyndromeDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone
MEDRTD010392PemphigusDISEASEmay_treattriamcinolone hexacetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD012216Rheumatic DiseasesDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone
MEDRTD012221Rhinitis, Allergic, PerennialDISEASEmay_treattriamcinolone hexacetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone hexacetonide
MEDRTD012536Scalp DermatosesDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone
MEDRTD012713Serum SicknessDISEASEmay_treattriamcinolone hexacetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone hexacetonide
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treattriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone
MEDRTD013224Status AsthmaticusDISEASEci_withtriamcinolone hexacetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone hexacetonide
MEDRTD013585SynovitisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone
MEDRTD013966ThyroiditisDISEASEmay_treattriamcinolone hexacetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone hexacetonide
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone
MEDRTD014605UveitisDISEASEmay_treattriamcinolone hexacetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone hexacetonide
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moatriamcinolone hexacetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone hexacetonide
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_petriamcinolone hexacetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone hexacetonide
MEDRTN0000008571Decreased Cytokine ActivityPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_petriamcinolone hexacetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone hexacetonide
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_petriamcinolone hexacetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone hexacetonide
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_petriamcinolone hexacetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone hexacetonide
MEDRTN0000008841Decreased Protein SynthesisPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_petriamcinolone hexacetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone hexacetonide
MEDRTN0000009739Lipid Metabolism AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_petriamcinolone hexacetonide

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH20 MG/ML (expressed as triamcinolone hexacetonide)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESPRESCRIBABLEY
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
ATTRIBUTESTTYSCD
CODESMMSL_CODECD3387
CODESRxCUI1085996
CODESSNOMEDCT782127002
CODESVUID4001623
NAMESPrescribable Synonymtriamcinolone hexacetonide 20 MG/ML Injectable Suspension
NAMESRXNAV_STRtriamcinolone hexacetonide 20 MG/ML Injectable Suspension
NAMESRxNorm Nametriamcinolone hexacetonide 20 MG/ML Injectable Suspension
SOURCESSourceMicromedex RED BOOK
SOURCESSourceNational Drug Data File Plus Source Vocabulary
SOURCESSourceUS Edition of SNOMED_CT
SOURCESSourceVeterans Health Administration National Drug File